1. Academic Validation
  2. Simultaneous determination of L-693,612, a topical carbonic anhydrase inhibitor, and two potential metabolites in human whole blood by ion-pair high-performance liquid chromatography

Simultaneous determination of L-693,612, a topical carbonic anhydrase inhibitor, and two potential metabolites in human whole blood by ion-pair high-performance liquid chromatography

  • J Chromatogr A. 1994 Feb 4;660(1-2):307-12. doi: 10.1016/0021-9673(94)85126-3.
E J Woolf 1 T Au M Kasper M Constanzer B Matuszewski
Affiliations

Affiliation

  • 1 Merck Research Laboratories, Department of Drug Metabolism, West Point, PA 19486.
Abstract

A method for the simultaneous determination of a topical Carbonic Anhydrase Inhibitor, L-693,612, and two of its potential metabolites in human whole blood is described. The analytes are isolated from the matrix via liquid-liquid extraction with a mixture of toluene, ethyl acetate and isopropanol (49:50:1, v/v/v). The analytes are then back extracted into dilute phosphoric acid prior to injection into the HPLC system. A cyano column (Zorbax SB-CN, 150 x 4.6 mm) with a mobile phase of phosphoric acid(0.085%)-acetonitrile (73.5:26.5) containing 10 mM sodium decane sulfonate and adjusted to pH 3 is used for the analysis. Detection is based on UV absorbance at 252 nm. The assay was found to be linear in the concentration range of 5-500 ng/ml for each analyte when 1-ml aliquots of whole blood were extracted.

Figures
Products